Mangoceuticals (MGRX) Cash & Current Investments (2023 - 2026)

Mangoceuticals has disclosed Cash & Current Investments across 4 years of filings, most recently posting $191519.0 for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $191519.0, up 104.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $191519.0 (up 104.97% YoY), and the FY2025 annual result was $1.5 million, up 8873.18% from the prior year.
• Cash & Current Investments came in at $191519.0 for Q1 2026 at Mangoceuticals, down from $1.5 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $2.9 million in Q2 2023 to a low of $15305.0 in Q1 2024.
• The 4-year median for Cash & Current Investments is $105699.5 (2025), against an average of $576664.1.
• Across the five-year window, Cash & Current Investments plunged 97.76% in 2024 and surged 8873.18% in 2025, its largest moves.
• Mangoceuticals' Cash & Current Investments stood at $755948.0 in 2023, then slumped by 97.76% to $16942.0 in 2024, then soared by 8873.18% to $1.5 million in 2025, then slumped by 87.4% to $191519.0 in 2026.
• The last three Cash & Current Investments figures came in at $191519.0 (Q1 2026), $1.5 million (Q4 2025), and $16942.0 (Q3 2025), per Business Quant data.